Prostate shapes on pre-treatment MRI between prostate cancer patients who do and do not undergo biochemical recurrence are different: Preliminary Findings

Early identification of PCa patients at risk for biochemical recurrence (BCR) post-therapy will potentially complement definitive therapy with either neo- or adjuvant therapy to improve prognosis. BCR post definitive therapy is often associated with disease progression that might cause a bulge in th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Ghose, Soumya, Shiradkar, Rakesh, Rusu, Mirabela, Mitra, Jhimli, Thawani, Rajat, Feldman, Michael, Gupta, Amar C., Purysko, Andrei S., Ponsky, Lee, Madabhushi, Anant
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696460/
https://ncbi.nlm.nih.gov/pubmed/29158516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-13443-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak